Form 4: Evolus Inc. Executive Rui Avelar Sells Shares to Cover Tax Obligations

Evolus Inc.'s Chief Medical Officer, Rui Avelar, sold 2,252 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Rui Avelar, Chief Medical Officer of Evolus Inc., sold 2,252 shares of common stock on December 23, 2024.
• The sale was executed at a price of $10.8519 per share.
• This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan.
• The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Avelar directly owns 366,595 shares of Evolus Inc. common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• Many companies use restricted stock units as part of their compensation packages, leading to similar sales when these units vest.
• The use of Rule 10b5-1 trading plans is a standard method for executives to avoid accusations of insider trading.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is generally considered a normal part of executive compensation.

Key Dates

Keywords

Evolus Inc., Rui Avelar, stock sale, Rule 10b5-1, insider trading, tax obligations, restricted stock units, EOLS